Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
0.3969
+0.0038 (0.97%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Leap Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 47.25 | 70.64 | 65.5 | 114.92 | 52.07 | Upgrade
|
| Cash & Short-Term Investments | 47.25 | 70.64 | 65.5 | 114.92 | 52.07 | Upgrade
|
| Cash Growth | -33.12% | 7.85% | -43.00% | 120.69% | 1238.24% | Upgrade
|
| Other Receivables | 0.7 | 0.77 | 2.1 | 1.19 | 0.07 | Upgrade
|
| Receivables | 0.7 | 0.77 | 2.1 | 1.19 | 0.07 | Upgrade
|
| Prepaid Expenses | 0.09 | 0.18 | 0.35 | 0.77 | 0.13 | Upgrade
|
| Total Current Assets | 48.04 | 71.6 | 67.95 | 116.87 | 52.27 | Upgrade
|
| Property, Plant & Equipment | 0.26 | 0.26 | 0.69 | 0.5 | 0.59 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | 0.16 | 0.18 | Upgrade
|
| Long-Term Deferred Charges | - | - | 0.58 | - | 0.35 | Upgrade
|
| Other Long-Term Assets | 0.82 | 0.97 | 1.14 | 0.38 | 0.98 | Upgrade
|
| Total Assets | 49.12 | 72.83 | 70.35 | 117.91 | 54.37 | Upgrade
|
| Accounts Payable | 4.74 | 6.47 | 5.66 | 4.19 | 2.72 | Upgrade
|
| Accrued Expenses | 8.54 | 5.96 | 5.15 | 5.37 | 2.75 | Upgrade
|
| Current Portion of Leases | 0.27 | 0.26 | 0.42 | 0.43 | 0.41 | Upgrade
|
| Current Income Taxes Payable | 0.53 | - | - | - | - | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 1.5 | Upgrade
|
| Total Current Liabilities | 14.08 | 12.68 | 11.23 | 9.99 | 7.37 | Upgrade
|
| Long-Term Leases | - | - | 0.26 | 0.04 | 0.14 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0.2 | Upgrade
|
| Total Liabilities | 14.08 | 12.68 | 11.49 | 10.02 | 7.72 | Upgrade
|
| Common Stock | 0.04 | 0.03 | 0.01 | 0.09 | 0.06 | Upgrade
|
| Additional Paid-In Capital | 502.5 | 459.59 | 376.9 | 371.64 | 270.16 | Upgrade
|
| Retained Earnings | -467.37 | -399.58 | -318.17 | -263.57 | -222.99 | Upgrade
|
| Comprehensive Income & Other | -0.12 | 0.11 | 0.13 | -0.27 | -0.58 | Upgrade
|
| Total Common Equity | 35.05 | 60.14 | 58.87 | 107.89 | 46.65 | Upgrade
|
| Shareholders' Equity | 35.05 | 60.14 | 58.87 | 107.89 | 46.65 | Upgrade
|
| Total Liabilities & Equity | 49.12 | 72.83 | 70.35 | 117.91 | 54.37 | Upgrade
|
| Total Debt | 0.27 | 0.26 | 0.68 | 0.47 | 0.55 | Upgrade
|
| Net Cash (Debt) | 46.98 | 70.38 | 64.82 | 114.45 | 51.52 | Upgrade
|
| Net Cash Growth | -33.25% | 8.58% | -43.36% | 122.14% | 1698.22% | Upgrade
|
| Net Cash Per Share | 1.25 | 3.44 | 5.72 | 13.33 | 8.68 | Upgrade
|
| Filing Date Shares Outstanding | 41.26 | 25.6 | 11.88 | 8.83 | 5.97 | Upgrade
|
| Total Common Shares Outstanding | 38.33 | 25.57 | 9.9 | 8.83 | 5.97 | Upgrade
|
| Working Capital | 33.96 | 58.91 | 56.73 | 106.89 | 44.9 | Upgrade
|
| Book Value Per Share | 0.91 | 2.35 | 5.94 | 12.22 | 7.82 | Upgrade
|
| Tangible Book Value | 35.05 | 60.14 | 58.87 | 107.89 | 46.65 | Upgrade
|
| Tangible Book Value Per Share | 0.91 | 2.35 | 5.94 | 12.22 | 7.82 | Upgrade
|
| Machinery | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | Upgrade
|
| Leasehold Improvements | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | Upgrade
|
Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.